Sionna Therapeutics, Inc.
SION
$11.87
-$0.17-1.41%
NASDAQ
| 12/31/2024 | |||||
|---|---|---|---|---|---|
| Net Income | -33.45% | ||||
| Total Depreciation and Amortization | 3.73% | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | -33.22% | ||||
| Change in Net Operating Assets | 0.55% | ||||
| Cash from Operations | -58.09% | ||||
| Capital Expenditure | 77.87% | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | 110.41% | ||||
| Cash from Investing | 113.64% | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | -- | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | -- | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | 729.32% | ||||